Glaxo and SmithKline directors could make millions from a mega- merger
Tuesday 03 February 1998
Executive directors of the pharmaceutical giants could net almost pounds 35m between them from the exercise of share options if the pounds 117bn merger is effected by a "newco" being formed to take over both groups. Options could also be triggered if one company ends up controlling more than 50 per cent of the enlarged group, signalling an effective takeover. SmithKline options will be triggered as both boards have agreed Glaxo shareholders would control 59.5 per cent of the new group.
Glaxo directors are also likely to receive massive pay increases to bring their rewards into line with their more lavishly remunerated counterparts at SmithKline.
It is SmithKline's directors that hold the largest tranche of options. They are sitting on combined share option profits of pounds 30m, according to figures published in the group's annual report. Glaxo directors stand to gain around pounds 4m.
Jan Leschly, SmithKline's chief executive, would be the biggest beneficiary. At the closing share price yesterday he held paper profits of almost pounds 17m including profits from US securities. Jean Pierre Garnier, chief operating officer, could make pounds 6.35m while Hugh Collum, the finance director could make pounds 3.3m.
Glaxo's executive chairman, Sir Richard Sykes, is sitting on options worth pounds 478,000. Dr James Niedel, research and development director, could net pounds 2.6m while Robert Ingram, another executive director, holds options worth pounds 1.4m.
The companies would not comment on possible payouts. Glaxo conceded it was accepted practice for options to be exercised if the deal was structured as a "newco" takeover.
If the merger goes ahead there are likely to be huge pay increases for the Glaxo executives who earn significantly less than their SmithKline counterparts.
Sir Richard Sykes was paid a total of pounds 1.1m in 1996 compared with Jan Leschly's pounds 2.1m. They will be executive chairman and chief executive respectively of the new group. Sir Richard would need at least to double his salary to take him ahead of SmithKline's Dr Jean Pierre-Garnier, who will be one of the merged group's executive directors. He earned pounds 1.96m last year.
The scale of the potential pay increases and options payments was criticised by some institutional investors yesterday. "This wouldn't be a reason they are doing the merger, would it?" one asked.
The deal could also lead to a pounds 400m fees bonanza for the company's advisers, including Lazards and Morgan Stanley.
Details of the pay bonanza emerged as pharmaceuticals shares soared. Glaxo was the major beneficiary of the market's new "drugs high" with its shares rocketing by 20.7 per cent to 1983p.
The surge added pounds 12bn to the company's market value while SmithKline's shares rose by more than 8 per cent, increasing its value by pounds 3.6bn. At these levels a combined Glaxo-SmithKline would be worth pounds 117bn.
Outlook, page 25
Harry Potter actor suffered 'severe flu-like symptoms' on a flight from London to Orlando
First full-length look is finally here
World cities ranked in terms of safety, food security and 'liveability'
- 2 The awkward moment Sarah Palin raised $25,000 for Hillary Clinton's election campaign
- 3 Ball pool for adults opens in London
- 4 Amal Clooney gives excellent response to fashion question at European Court of Human Rights
- 5 Baldness could soon be treated using stem cells, scientists hope
Woman falls to her death as she celebrates marriage proposal at the edge of Ibiza cliff
Sex abuse inquiry: 'Victims receive death threats' after MPs release names online
Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
Teenager brandishing fake gun taken down by police after demanding airtime on Netherlands' NOS TV station
The awkward moment Sarah Palin raised $25,000 for Hillary Clinton's election campaign
9 reasons Greece's experiment with the radical left is doomed to failure
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
Have we reached 'peak food'? Shortages loom as global production rates slow
Greece elections: Syriza and EU on collision course after election win for left-wing party
British grandmother Lindsay Sandiford faces execution by firing squad in Indonesia
Liberal Democrat minister defends comments suggesting immigration causes pub closures
iJobs Money & Business
£30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...
£13000 per annum: Recruitment Genius: This Pension Specialist was established ...
£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...
£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...